Literature DB >> 23146279

Optimized local infarct restraint improves left ventricular function and limits remodeling.

Kevin J Koomalsingh1, Walter R T Witschey, Jeremy R McGarvey, Takashi Shuto, Norihiro Kondo, Chun Xu, Benjamin M Jackson, Joseph H Gorman, Robert C Gorman, James J Pilla.   

Abstract

BACKGROUND: Preventing expansion and dyskinetic movement of a myocardial infarction (MI) can limit left ventricular (LV) remodeling. Using a device designed to produce variable alteration of infarct stiffness and geometry, we sought to understand how these parameters affect LV function and remodeling early after MI.
METHODS: Ten pigs had posterolateral infarctions. An unexpanded device was placed in 5 animals at the time of infarction and 5 animals served as untreated controls. One week after MI animals underwent magnetic resonance imaging to assess LV size and regional function. In the treatment group, after initial imaging, the device was expanded with 2, 4, 6, 8, and 10 mL of saline. The optimal degree of inflation was defined as that which maximized stroke volume (SV). The device was left optimally inflated in the treatment animals for 3 additional weeks.
RESULTS: One week after MI, device inflation to 6 mL or greater significantly (p < 0.05) decreased end-systolic volume (0 mL, 59.9 mL ± 3.8; 6 mL, 54.0 mL ± 3.1; 8 mL, 50.5 mL ± 4.8; and 10 mL, 46.1 mL ± 2.2) and increased ejection fraction (EF) (0 mL, 0.346 ± 0.016; 6 mL, 0.0397 ± 0.009; 8 mL, 0.431 ± 0.027; and 10 mL, 0.441 ± 0.009). Systolic volume significantly (p < 0.05) improved for the 6 mL and 8 mL volumes (0 mL, 31.2 mL ± 2.6; 6 mL, 35.7 mL ± 2.0; and 8 mL, 37.5 mL ± 1.9) but trended downward for 10 mL (36.6 mL ± 2.8). At 4 weeks after MI, end-diastolic volume and end-systolic volume were unchanged from 1-week values in the treatment group while the control group continued to dilate. Systolic volume (38.2 ± 4.4 mL vs 34.0.1 ± 4.8 mL, p = 0.08) and EF (0.360 ± 0.026 vs 0.276 ± 0.014, p = 0.04) were also better in the treatment animals.
CONCLUSIONS: Optimized isolated infarct restraint can limit adverse LV remodeling after MI. The tested device affords the potential for a patient-specific therapy to preserve cardiac function after MI.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23146279      PMCID: PMC3607370          DOI: 10.1016/j.athoracsur.2012.08.056

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  23 in total

1.  Regional wall stress predicts ventricular remodeling after anteroseptal myocardial infarction in the Healing and Early Afterload Reducing Trial (HEART): an echocardiography-based structural analysis.

Authors:  Y Aikawa; L Rohde; J Plehn; S C Greaves; F Menapace; M O Arnold; J L Rouleau; M A Pfeffer; R T Lee; S D Solomon
Journal:  Am Heart J       Date:  2001-02       Impact factor: 4.749

Review 2.  Chronic heart failure in the United States: a manifestation of coronary artery disease.

Authors:  M Gheorghiade; R O Bonow
Journal:  Circulation       Date:  1998-01-27       Impact factor: 29.690

Review 3.  Structure and mechanics of healing myocardial infarcts.

Authors:  Jeffrey W Holmes; Thomas K Borg; James W Covell
Journal:  Annu Rev Biomed Eng       Date:  2005       Impact factor: 9.590

4.  Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction.

Authors:  L E Rohde; M Aikawa; G C Cheng; G Sukhova; S D Solomon; P Libby; J Pfeffer; M A Pfeffer; R T Lee
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

5.  Early ventricular restraint after myocardial infarction: extent of the wrap determines the outcome of remodeling.

Authors:  Yoshiharu Enomoto; Joseph H Gorman; Sina L Moainie; Benjamin M Jackson; Landi M Parish; Theodore Plappert; Ahmad Zeeshan; Martin G St John-Sutton; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2005-03       Impact factor: 4.330

6.  Reverse ventricular remodeling reduces ischemic mitral regurgitation: echo-guided device application in the beating heart.

Authors:  Judy Hung; J Luis Guerrero; Mark D Handschumacher; Gregory Supple; Suzanne Sullivan; Robert A Levine
Journal:  Circulation       Date:  2002-11-12       Impact factor: 29.690

7.  Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation.

Authors:  K B Gupta; M B Ratcliffe; M A Fallert; L H Edmunds; D K Bogen
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

8.  Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction.

Authors:  S T Kelley; R Malekan; J H Gorman; B M Jackson; R C Gorman; Y Suzuki; T Plappert; D K Bogen; M G Sutton; L H Edmunds
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

9.  Extension of borderzone myocardium in postinfarction dilated cardiomyopathy.

Authors:  Benjamin M Jackson; Joseph H Gorman; Sina L Moainie; T Sloane Guy; Navneet Narula; Jagat Narula; Martin G John-Sutton; L Henry Edmunds; Robert C Gorman
Journal:  J Am Coll Cardiol       Date:  2002-09-18       Impact factor: 24.094

10.  An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle.

Authors:  D K Bogen; S A Rabinowitz; A Needleman; T A McMahon; W H Abelmann
Journal:  Circ Res       Date:  1980-11       Impact factor: 17.367

View more
  8 in total

1.  Regional myocardial three-dimensional principal strains during postinfarction remodeling.

Authors:  James J Pilla; Kevin J Koomalsingh; Jeremy R McGarvey; Walter R T Witschey; Larry Dougherty; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2015-01-23       Impact factor: 4.330

Review 2.  Physiological Implications of Myocardial Scar Structure.

Authors:  William J Richardson; Samantha A Clarke; T Alexander Quinn; Jeffrey W Holmes
Journal:  Compr Physiol       Date:  2015-09-20       Impact factor: 9.090

3.  Effect of Scar Compaction on the Therapeutic Efficacy of Anisotropic Reinforcement Following Myocardial Infarction in the Dog.

Authors:  Samantha A Clarke; Norman C Goodman; Gorav Ailawadi; Jeffrey W Holmes
Journal:  J Cardiovasc Transl Res       Date:  2015-06-16       Impact factor: 4.132

4.  Injectable microsphere gel progressively improves global ventricular function, regional contractile strain, and mitral regurgitation after myocardial infarction.

Authors:  Jeremy R McGarvey; Norihiro Kondo; Walter R T Witschey; Manabu Takebe; Chikashi Aoki; Jason A Burdick; Francis G Spinale; Joseph H Gorman; James J Pilla; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2014-12-15       Impact factor: 4.330

5.  Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.

Authors:  John W Macarthur; Jeffrey E Cohen; Jeremy R McGarvey; Yasuhiro Shudo; Jay B Patel; Alen Trubelja; Alexander S Fairman; Bryan B Edwards; George Hung; William Hiesinger; Andrew B Goldstone; Pavan Atluri; Robert L Wilensky; James J Pilla; Joseph H Gorman; Robert C Gorman; Y Joseph Woo
Journal:  Circ Res       Date:  2013-12-23       Impact factor: 17.367

6.  Directed epicardial assistance in ischemic cardiomyopathy: flow and function using cardiac magnetic resonance imaging.

Authors:  Jeremy R McGarvey; Norihiro Kondo; Manabu Takebe; Kevin J Koomalsingh; Walter R T Witschey; Alex J Barker; Michael Markl; Satoshi Takebayashi; Toru Shimaoka; Joseph H Gorman; Robert C Gorman; James J Pilla
Journal:  Ann Thorac Surg       Date:  2013-06-26       Impact factor: 4.330

7.  Slice-by-Slice Pressure-Volume Loop Analysis Demonstrates Native Differences in Regional Cardiac Contractility and Response to Inotropic Agents.

Authors:  Francisco J Contijoch; Walter R T Witschey; Jeremy McGarvey; Madonna E Lee; Joseph Gorman; Robert C Gorman; James J Pilla
Journal:  Ann Thorac Surg       Date:  2016-04-23       Impact factor: 4.330

Review 8.  Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease.

Authors:  Robert G Gourdie; Stefanie Dimmeler; Peter Kohl
Journal:  Nat Rev Drug Discov       Date:  2016-06-24       Impact factor: 84.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.